Annual report
5194.TEDINET S100TTZK
Period2023-04-01 → 2024-03-31
Filed2024-06-26
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 148
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥6.1bn | 2023-04-01 → 2024-03-31 | Cons. | Net sales |
| Revenue | ¥6.0bn | 2022-04-01 → 2023-03-31 | Cons. | Net sales |
| Revenue | ¥5.4bn | 2021-04-01 → 2022-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥5.6bn | 2020-04-01 → 2021-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥6.6bn | 2019-04-01 → 2020-03-31d | Cons. | Net sales (5-year summary) |
| Operating income | ¥436m | 2023-04-01 → 2024-03-31 | Cons. | Operating income |
| Operating income | ¥661m | 2022-04-01 → 2023-03-31 | Cons. | Operating income |
| Ordinary income | ¥389m | 2023-04-01 → 2024-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥1.1bn | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥1.5bn | 2021-04-01 → 2022-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.0bn | 2020-04-01 → 2021-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.3bn | 2019-04-01 → 2020-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥357m | 2023-04-01 → 2024-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥1.1bn | 2022-04-01 → 2023-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥41m | 2023-04-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥674m | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥1.1bn | 2021-04-01 → 2022-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥598m | 2020-04-01 → 2021-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥902m | 2019-04-01 → 2020-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥2m | 2023-04-01 → 2024-03-31 | Cons. | Profit loss |
| Net income | ¥672m | 2022-04-01 → 2023-03-31 | Cons. | Profit loss |
| Total assets | ¥17.7bn | at 2024-03-31 | Cons. | Assets |
| Total assets | ¥18.1bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥17.0bn | at 2022-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥15.7bn | at 2021-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥16.1bn | at 2020-03-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥7.6bn | at 2024-03-31 | Cons. | Liabilities |
| Total liabilities | ¥8.2bn | at 2023-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥10.1bn | at 2024-03-31 | Cons. | Net assets |
| Net assets / equity | ¥9.9bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥8.9bn | at 2022-03-31d | Cons. | Net assets |
| Net assets / equity | ¥7.6bn | at 2021-03-31d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥7.2bn | at 2020-03-31d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥1.2bn | at 2024-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥1.8bn | at 2023-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥1.2bn | at 2024-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.8bn | at 2023-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.5bn | at 2022-03-31d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.5bn | at 2021-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥1.6bn | at 2020-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥374m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥899m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥905m | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥1.4bn | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥1.2bn | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥133m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥185m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥676m | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥2.2bn | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥608m | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥907m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥422m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥190m | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥671m | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥86m | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥3.77 | 2023-04-01 → 2024-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥62.04 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥101.1 | 2021-04-01 → 2022-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥55.08 | 2020-04-01 → 2021-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥83.1 | 2019-04-01 → 2020-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥906.81 | at 2024-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥889.52 | at 2023-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥797.34 | at 2022-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥675.55 | at 2021-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥640 | at 2020-03-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 55.6% | at 2024-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 53.2% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 50.8% | at 2022-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 46.7% | at 2021-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 43.1% | at 2020-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 0.4% | 2023-04-01 → 2024-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 7.4% | 2022-04-01 → 2023-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 13.7% | 2021-04-01 → 2022-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 8.4% | 2020-04-01 → 2021-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 13.7% | 2019-04-01 → 2020-03-31d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 854 | at 2024-03-31 | Cons. | Number of employees |
| Employees | 809 | at 2023-03-31 | Cons. | Number of employees |
| Employees | 796 | at 2022-03-31d | Cons. | Number of employees |
| Employees | 871 | at 2021-03-31d | Cons. | Number of employees |
| Employees | 862 | at 2020-03-31d | Cons. | Number of employees |
| Revenue | ¥6.1bn | 2023-04-01 → 2024-03-31 | Standalone | Net sales |
| Revenue | ¥5.9bn | 2022-04-01 → 2023-03-31 | Standalone | Net sales |
| Revenue | ¥5.8bn | 2021-04-01 → 2022-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥5.5bn | 2020-04-01 → 2021-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥8.2bn | 2019-04-01 → 2020-03-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥987m | 2023-04-01 → 2024-03-31 | Standalone | Operating income |
| Operating income | ¥1.1bn | 2022-04-01 → 2023-03-31 | Standalone | Operating income |
| Ordinary income | ¥1.0bn | 2023-04-01 → 2024-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥1.1bn | 2022-04-01 → 2023-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥1.1bn | 2021-04-01 → 2022-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.2bn | 2020-04-01 → 2021-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.6bn | 2019-04-01 → 2020-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥1.0bn | 2023-04-01 → 2024-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥1.1bn | 2022-04-01 → 2023-03-31 | Standalone | Income before income taxes |
| Net income | ¥683m | 2023-04-01 → 2024-03-31 | Standalone | Profit loss |
| Net income | ¥757m | 2022-04-01 → 2023-03-31 | Standalone | Profit loss |
| Net income | ¥690m | 2021-04-01 → 2022-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥770m | 2020-04-01 → 2021-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥1.1bn | 2019-04-01 → 2020-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥16.6bn | at 2024-03-31 | Standalone | Assets |
| Total assets | ¥16.4bn | at 2023-03-31 | Standalone | Assets |
| Total assets | ¥15.9bn | at 2022-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥16.4bn | at 2021-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥16.6bn | at 2020-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥5.3bn | at 2024-03-31 | Standalone | Liabilities |
| Total liabilities | ¥5.8bn | at 2023-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥11.3bn | at 2024-03-31 | Standalone | Net assets |
| Net assets / equity | ¥10.5bn | at 2023-03-31 | Standalone | Net assets |
| Net assets / equity | ¥9.8bn | at 2022-03-31d | Standalone | Net assets |
| Net assets / equity | ¥9.2bn | at 2021-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥8.5bn | at 2020-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥491m | at 2024-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥1.2bn | at 2023-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥62.95 | 2023-04-01 → 2024-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥69.71 | 2022-04-01 → 2023-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥63.58 | 2021-04-01 → 2022-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥70.95 | 2020-04-01 → 2021-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥98.66 | 2019-04-01 → 2020-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| Dividend per share | ¥10 | 2023-04-01 → 2024-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥10 | 2022-04-01 → 2023-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥10 | 2021-04-01 → 2022-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥10 | 2020-04-01 → 2021-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥10 | 2019-04-01 → 2020-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥1,039.55 | at 2024-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥968.63 | at 2023-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥905.27 | at 2022-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥851.12 | at 2021-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥781.9 | at 2020-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 67.9% | at 2024-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 64.3% | at 2023-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 61.7% | at 2022-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 56.3% | at 2021-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 51.1% | at 2020-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 6.3% | 2023-04-01 → 2024-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 7.4% | 2022-04-01 → 2023-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 7.2% | 2021-04-01 → 2022-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 8.7% | 2020-04-01 → 2021-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 13.3% | 2019-04-01 → 2020-03-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 10,937,000 | at 2024-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 10,937,000 | at 2023-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 10,937,000 | at 2022-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 10,937,000 | at 2021-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 10,937,000 | at 2020-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 197 | at 2024-03-31 | Standalone | Number of employees |
| Employees | 195 | at 2023-03-31 | Standalone | Number of employees |
| Employees | 207 | at 2022-03-31d | Standalone | Number of employees |
| Employees | 207 | at 2021-03-31d | Standalone | Number of employees |
| Employees | 212 | at 2020-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 76
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | capex | 2023-04-01 → 2024-03-31 | ¥889,000 |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | depreciation | 2023-04-01 → 2024-03-31 | ¥9m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | employees | at 2024-03-31 | 35 pure |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2023-04-01 → 2024-03-31 | ¥209m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2023-04-01 → 2024-03-31 | ¥209m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment assets | at 2024-03-31 | ¥264m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2023-04-01 → 2024-03-31 | −¥91m |
| Reconciling Itemsreconciling | capex | 2023-04-01 → 2024-03-31 | ¥7m |
| Reconciling Itemsreconciling | depreciation | 2023-04-01 → 2024-03-31 | ¥12m |
| Reconciling Itemsreconciling | segment assets | at 2024-03-31 | ¥1.3bn |
| Reconciling Itemsreconciling | segment profit | 2023-04-01 → 2024-03-31 | −¥454m |
| Health Care Businessreportable segment | capex | 2023-04-01 → 2024-03-31 | ¥108m |
| Health Care Businessreportable segment | depreciation | 2023-04-01 → 2024-03-31 | ¥623m |
| Health Care Businessreportable segment | employees | at 2024-03-31 | 746 pure |
| Health Care Businessreportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥4.7bn |
| Health Care Businessreportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥4.7bn |
| Health Care Businessreportable segment | segment assets | at 2024-03-31 | ¥15.2bn |
| Health Care Businessreportable segment | segment profit | 2023-04-01 → 2024-03-31 | ¥979m |
| Plastic Products Businessreportable segment | capex | 2023-04-01 → 2024-03-31 | ¥6m |
| Plastic Products Businessreportable segment | depreciation | 2023-04-01 → 2024-03-31 | ¥14m |
| Plastic Products Businessreportable segment | employees | at 2024-03-31 | 50 pure |
| Plastic Products Businessreportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥1.2bn |
| Plastic Products Businessreportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥1.2bn |
| Plastic Products Businessreportable segment | segment assets | at 2024-03-31 | ¥971m |
| Plastic Products Businessreportable segment | segment profit | 2023-04-01 → 2024-03-31 | ¥3m |
| —segment total | capex | 2023-04-01 → 2024-03-31 | ¥114m |
| —segment total | depreciation | 2023-04-01 → 2024-03-31 | ¥637m |
| —segment total | employees | at 2024-03-31 | 796 pure |
| —segment total | revenue | 2023-04-01 → 2024-03-31 | ¥5.9bn |
| —segment total | revenue external | 2023-04-01 → 2024-03-31 | ¥5.9bn |
| —segment total | segment assets | at 2024-03-31 | ¥16.2bn |
| —segment total | segment profit | 2023-04-01 → 2024-03-31 | ¥981m |
| Total Of Reportable Segments And Otherssegment total | capex | 2023-04-01 → 2024-03-31 | ¥115m |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2023-04-01 → 2024-03-31 | ¥646m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-04-01 → 2024-03-31 | ¥6.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-04-01 → 2024-03-31 | ¥6.1bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2024-03-31 | ¥16.4bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-04-01 → 2024-03-31 | ¥891m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | capex | 2022-04-01 → 2023-03-31 | ¥3m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | depreciation | 2022-04-01 → 2023-03-31 | ¥9m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-04-01 → 2023-03-31 | ¥227m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-04-01 → 2023-03-31 | ¥227m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment assets | at 2023-03-31 | ¥277m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-04-01 → 2023-03-31 | −¥67m |
| Reconciling Itemsreconciling | capex | 2022-04-01 → 2023-03-31 | ¥5m |
| Reconciling Itemsreconciling | depreciation | 2022-04-01 → 2023-03-31 | ¥11m |
| Reconciling Itemsreconciling | segment assets | at 2023-03-31 | ¥1.7bn |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2023-03-31 | −¥332m |
| Health Care Businessreportable segment | capex | 2022-04-01 → 2023-03-31 | ¥177m |
| Health Care Businessreportable segment | depreciation | 2022-04-01 → 2023-03-31 | ¥579m |
| Health Care Businessreportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥4.5bn |
| Health Care Businessreportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥4.5bn |
| Health Care Businessreportable segment | segment assets | at 2023-03-31 | ¥15.2bn |
| Health Care Businessreportable segment | segment profit | 2022-04-01 → 2023-03-31 | ¥1.1bn |
| Plastic Products Businessreportable segment | capex | 2022-04-01 → 2023-03-31 | ¥10m |
| Plastic Products Businessreportable segment | depreciation | 2022-04-01 → 2023-03-31 | ¥14m |
| Plastic Products Businessreportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥1.3bn |
| Plastic Products Businessreportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥1.3bn |
| Plastic Products Businessreportable segment | segment assets | at 2023-03-31 | ¥964m |
| Plastic Products Businessreportable segment | segment profit | 2022-04-01 → 2023-03-31 | −¥25m |
| —segment total | capex | 2022-04-01 → 2023-03-31 | ¥187m |
| —segment total | depreciation | 2022-04-01 → 2023-03-31 | ¥593m |
| —segment total | revenue | 2022-04-01 → 2023-03-31 | ¥5.8bn |
| —segment total | revenue external | 2022-04-01 → 2023-03-31 | ¥5.8bn |
| —segment total | segment assets | at 2023-03-31 | ¥16.1bn |
| —segment total | segment profit | 2022-04-01 → 2023-03-31 | ¥1.1bn |
| Total Of Reportable Segments And Otherssegment total | capex | 2022-04-01 → 2023-03-31 | ¥189m |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2022-04-01 → 2023-03-31 | ¥602m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2023-03-31 | ¥6.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2023-03-31 | ¥6.0bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2023-03-31 | ¥16.4bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2023-03-31 | ¥993m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | employees | at 2024-03-31 | 33 pure |
| Health Care Businessreportable segment | employees | at 2024-03-31 | 91 pure |
| Plastic Products Businessreportable segment | employees | at 2024-03-31 | 50 pure |
| —segment total | employees | at 2024-03-31 | 141 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,516
| Item | Context | Value | Unit |
|---|---|---|---|
| Current liabilities | CurrentYearInstant | 6716775000 | JPY |
| Long term loans payable | Prior1YearInstant | 952913000 | JPY |
| Long term loans payable | CurrentYearInstant | 420897000 | JPY |
| Long term guarantee deposited | Prior1YearInstant | 2000000 | JPY |
| Long term guarantee deposited | CurrentYearInstant | 2000000 | JPY |
| Net defined benefit liability | Prior1YearInstant | 82393000 | JPY |
| Net defined benefit liability | CurrentYearInstant | 75131000 | JPY |
| Provision for directors retirement benefits | Prior1YearInstant | 437048000 | JPY |
| Provision for directors retirement benefits | CurrentYearInstant | 392835000 | JPY |
| Asset retirement obligations ncl | Prior1YearInstant | 5399000 | JPY |
| Asset retirement obligations ncl | CurrentYearInstant | 5400000 | JPY |
| Noncurrent liabilities | Prior1YearInstant | 1479754000 | JPY |
| Noncurrent liabilities | CurrentYearInstant | 896263000 | JPY |
| Liabilities | Prior1YearInstant | 8200980000 | JPY |
| Liabilities | CurrentYearInstant | 7613038000 | JPY |
| Capital stock | Prior1YearInstant | 547436000 | JPY |
| Capital stock | CurrentYearInstant | 547436000 | JPY |
| Capital surplus | Prior1YearInstant | 676518000 | JPY |
| Capital surplus | CurrentYearInstant | 676518000 | JPY |
| Retained earnings | Prior1YearInstant | 8563418000 | JPY |
| Retained earnings | CurrentYearInstant | 8495806000 | JPY |
| Treasury stock | Prior1YearInstant | -35995000 | JPY |
| Treasury stock | CurrentYearInstant | -36308000 | JPY |
| Shareholders equity | Prior1YearInstant | 9751378000 | JPY |
| Shareholders equity | CurrentYearInstant | 9683451000 | JPY |
| Valuation difference on available for sale securities | Prior1YearInstant | 232115000 | JPY |
| Valuation difference on available for sale securities | CurrentYearInstant | 427191000 | JPY |
| Foreign currency translation adjustment | Prior1YearInstant | -326063000 | JPY |
| Foreign currency translation adjustment | CurrentYearInstant | -265859000 | JPY |
| Valuation and translation adjustments | Prior1YearInstant | -93948000 | JPY |
| Valuation and translation adjustments | CurrentYearInstant | 161331000 | JPY |
| Non controlling interests | Prior1YearInstant | 289963000 | JPY |
| Non controlling interests | CurrentYearInstant | 258573000 | JPY |
| Net assets | Prior1YearInstant | 9947393000 | JPY |
| Net assets | CurrentYearInstant | 10103357000 | JPY |
| Liabilities and net assets | Prior1YearInstant | 18148373000 | JPY |
| Liabilities and net assets | CurrentYearInstant | 17716395000 | JPY |
| Net sales | Prior1YearDuration | 5984735000 | JPY |
| Net sales | CurrentYearDuration | 6112570000 | JPY |
| Cost of sales | Prior1YearDuration | 4092190000 | JPY |
| Cost of sales | CurrentYearDuration | 4286451000 | JPY |
| Gross profit | Prior1YearDuration | 1892544000 | JPY |
| Gross profit | CurrentYearDuration | 1826118000 | JPY |
| Selling general and administrative expenses | Prior1YearDuration | 1231276000 | JPY |
| Selling general and administrative expenses | CurrentYearDuration | 1389674000 | JPY |
| Operating income | Prior1YearDuration | 661268000 | JPY |
| Operating income | CurrentYearDuration | 436443000 | JPY |
| Interest income noi | Prior1YearDuration | 1730000 | JPY |
| Interest income noi | CurrentYearDuration | 10000 | JPY |
| Dividends income noi | Prior1YearDuration | 19965000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |